Skip to main content
. 2022 Mar 7;17(10):929–938. doi: 10.1093/scan/nsac016

Table 1.

Characteristics of the autistic and non-autistic women included in the analysis

Autistic (n = 16) Non-autistic (n = 21) P
Age (years) 29.9 ± 8.4 26.4 ± 7.9 0.20
Full-scale IQ 121 ± 16.4 117.9 ± 13.7 0.52
Hormonal contraceptive use (n) 0 6 0.01*
Psychological traits
AQ 37.1 ± 5.2 13.2 ± 6.6 <0.001**
LSAS 73.3 ± 24.2 31.71 ± 13.6 <0.001**
Salivary oxytocin (pg/ml)
Placebo condition
Baseline 3.3 ± 0.9 3.0 ± 0.9 0.17
Immediately post-administration 3.0 ± 0.9 2.7 ± 0.8 0.32
90-min post-administration 2.9 ± 1.0 2.6 ± 0.7 0.30
Oxytocin condition
Baseline 2.8 ± 0.9 2.9 ± 0.8 0.89
Immediately post-administration 112.9 ± 15.1 113.5 ± 16.0 0.91
90-min post-administration 46.1 ± 15.6 35.3 ± 21.3 0.08

Full-scale IQ = Wechsler abbreviated scale of intelligence,

*

P < 0.05,

**

P < 0.01.